Uche Nnaji
⚠️ High Risk
FEI: 3007017159 • Lagoslagos • NIGERIA
FEI Number
3007017159
Location
Lagoslagos
Country
NIGERIAAddress
Blk 3 H6b Seegnal Pharmamobolaji Johnson, , Lagoslagos, , Nigeria
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 7/29/2008 | 61ECA08LORATADINE (ANTI-ASTHMATIC) | 118NOT LISTED | Cincinnati District Office (CIN-DO) |
| 7/29/2008 | 62GCA90DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/29/2008 | 62GCA90DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/29/2008 | 56ECE20DOXYCYCLINE (TETRACYCLINES) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/29/2008 | 56ECE20DOXYCYCLINE (TETRACYCLINES) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/29/2008 | 66VCA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/29/2008 | 56KCE10CHLORAMPHENICOL | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/29/2008 | 62LDA23AMODIAQUINE HCL (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 7/29/2008 | 56DCK70STREPTOMYCIN (AMINOGLYCOSIDES) | Cincinnati District Office (CIN-DO) | |
| 7/29/2008 | 56DCK20GENTAMICIN (AMINOGLYCOSIDES) | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is Uche Nnaji's FDA import refusal history?
Uche Nnaji (FEI: 3007017159) has 10 FDA import refusal record(s) in our database, spanning from 7/29/2008 to 7/29/2008.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Uche Nnaji's FEI number is 3007017159.
What types of violations has Uche Nnaji received?
Uche Nnaji has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Uche Nnaji come from?
All FDA import refusal data for Uche Nnaji is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.